acambis plc new ceo is selected amid restructuring acambis plc announced a management overhaul and a restructuring the england based developer of vaccines against infectious diseases said ian garland will succeed chief executive officer gordon cameron as of june mr garland had been chief financial officer of arrow therapeutics ltd chief financial officer david lawrence will be succeeded on an interim basis by elizbeth brown vice president of financial management acambis also said it will cut of its member staff 
